PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include testosterone in older men, carotid procedures in those without symptoms, pioglitazone after a stroke, and managing Ebola in the U.S. and Europe (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 20, 2016 Category: Cardiology Source Type: news
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
LOS ANGELES – Nondiabetic, insulin-resistant patients who started pioglitazone within 6 months of an ischemic stroke or transient ischemic attack had almost a 3% absolute risk reduction in secondary... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 19, 2016 Category: Endocrinology Source Type: news
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
LOS ANGELES – Nondiabetic, insulin-resistant patients who started pioglitazone within 6 months of an ischemic stroke or transient ischemic attack had almost a 3% absolute risk reduction in secondary... (Source: Clinical Neurology News)
Source: Clinical Neurology News - February 19, 2016 Category: Neurology Source Type: news
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
LOS ANGELES – Nondiabetic, insulin-resistant patients who started pioglitazone within 6 months of an ischemic stroke or transient ischemic attack had almost a 3% absolute risk reduction in secondary... (Source: Family Practice News)
Source: Family Practice News - February 19, 2016 Category: Primary Care Source Type: news
Feb 19 Cardiology NewsFeb 19 Cardiology News
Carotid stenting vs surgery, leadless pacing, the CMS decision on Watchman, pioglitazone after stroke, and subretinal bleeding with antithrombins are discussed by Dr John Mandrola this week. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 19, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Tackling insulin resistance may reduce recurrence after stroke
Giving pioglitazone to stroke survivors with insulin resistance but no overt diabetes reduces their risk of having a recurrent vascular event, shows the randomised Insulin Resistance Intervention after Stroke trial. (Source: MedWire News)
Source: MedWire News - February 19, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Follow-Up: Pioglitazone for Secondary Prevention (FREE)
By the Editors
Clinical Conversations interviews the author of an editorial in the New England … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 19, 2016 Category: Primary Care Source Type: news
Diabetes drug may prevent recurring strokes
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack. (Source: World Pharma News)
Source: World Pharma News - February 18, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Pioglitazone for Secondary Prevention in Vascular Disease? (FREE)
By Joe Elia
Edited by Jaye Elizabeth Hefner, MD
Pioglitazone, which lowers insulin resistance, may help in the secondary prevention of vascular events, suggests a study presented at the International Stroke Conference and published in the New England … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 18, 2016 Category: Primary Care Source Type: news
Diabetes Drug May Help Prevent Second Stroke
Actos reduced risk by 24 percent in people with insulin resistance, research showed (Source: WebMD Health)
Source: WebMD Health - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke: Study
Actos reduced risk by 24 percent in people with insulin resistance, research showed (Source: WebMD Health)
Source: WebMD Health - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes drug may prevent heart attack, recurring stroke
Stephen FellerNEW HAVEN, Conn., Feb. 17 (UPI) -- The diabetes drug Actos was shown to lower the risk of recurring stroke and heart attack in a large clinical trial of insulin-resistant stroke patients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke: Study
Actos reduced risk by 24 percent in people with insulin resistance, research showed (Source: U.S. News - Health)
Source: U.S. News - Health - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke
Actos reduced risk by 24 percent in people with insulin resistance, research showed
Source: HealthDay
Related MedlinePlus Pages: Diabetes Medicines, Stroke (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 17, 2016 Category: Consumer Health News Source Type: news
IRIS: Diabetes Drug Reduces Recurrent Stroke, MIIRIS: Diabetes Drug Reduces Recurrent Stroke, MI
A randomized trial shows that in patients with insulin resistance but no diabetes and a history of recent stroke or TIA, pioglitazone reduced recurrent stroke and myocardial infarction vs placebo. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 17, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
